Familial hypercholesterolemia complicated with multiple xanthomas in a child: a case report
Year: 2026
Type: article
Study design: Case Report
Abstract: Familial hypercholesterolemia (FH) is a hereditary disorder primarily due to variants of low-density lipoprotein receptor (LDLR) gene, characterized by markedly elevated plasma low-density lipoprotein cholesterol (LDL-C) levels and a severely increased risk of premature atherosclerotic cardiovascular disease (ASCVD). For rare homozygous FH (HoFH), the condition is particularly severe and the treatment is extremely challenging. This case described a pediatric HoFH patient presenting with multiple xanthomas and a LDL-C level of 17.95 mmol/L (694.04 mg/dL). Genetic testing further revealed compound heterozygous variants in the LDLR gene: a missense variant (NM_000527.5:c.298G>A) and a classic splicing variant (NM_000527.5:c.817+1G>A), confirming the diagnosis of biallelic semidominant hypercholesterolemia, monogenic (same gene, different variants). The patient received triple combination therapy with atorvastatin, ezetimibe and evolocumab, and actively improved his lifestyle. After nearly two years of follow-up, his LDL-C levels decreased from baseline to 14.23 mmol/L (550.59 mg/dL). However, this failed to reach the therapeutic goal and cutaneous xanthomas at the joints showed no significant regression. For such patients with severe defects in LDLR function, agents independent of LDLR pathway, LDL apheresis, or even liver transplantation should be initiated early to improve long-term prognosis. This report underscores the role of prioritizing phenotypic identification, targeted genetic testing, strengthening medical cooperation and maximizing local advantages in optimizing the management of HoFH especially within resource constraints, advocating for the establishment of a fast-track path for approval and supervision of new drugs for HoFH covered by official medical subsidies and LDL apheresis centers specialized for children in China.
Source: BMC Pediatrics
Authors: Jingqi Li, Yingfen Qin
Language: English
Subfield: Cardiology and Cardiovascular Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $3,090
OpenAlex ID: W7236627288
